Clinical Trial Update: Change in Patient-repOrted Outcomes in COPD Patients Newly Initiated on TRIXEO AEROSPHERE in Real worlD

View source ↗

Summary

Real-world study update showing changes in patient-reported outcomes for chronic obstructive pulmonary disease patients newly started on TRIXEO AEROSPHERE; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Trixeo Aerosphere (budesonide/formoterol/glycopyrronium)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Status: COMPLETED